Bon Natural Life Ltd. Files Routine 6-K Disclosure

Ticker: BON · Form: 6-K · Filed: Apr 23, 2025 · CIK: 1816815

Sentiment: neutral

Topics: disclosure, routine-filing, foreign-private-issuer

Related Tickers: BNL

TL;DR

Bon Natural Life (BNL) filed a 6-K, standard disclosure, no major news.

AI Summary

Bon Natural Life Ltd. filed a Form 6-K on April 23, 2025, reporting as a foreign private issuer. The company, incorporated in E9 with a fiscal year end of September 30, is primarily involved in medicinal chemicals and botanical products. The filing does not contain specific financial figures or operational updates but serves as a routine disclosure.

Why It Matters

This filing indicates ongoing compliance and reporting by Bon Natural Life Ltd. as a publicly traded entity, providing transparency to investors.

Risk Assessment

Risk Level: low — This is a routine administrative filing with no new material financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information which the issuer makes or is required to make public in its home country.

What is the filing date of this Form 6-K?

The filing date is April 23, 2025.

What is the SEC File Number for Bon Natural Life Ltd?

The SEC File Number for Bon Natural Life Ltd is 001-40517.

What is the primary business of Bon Natural Life Ltd?

Bon Natural Life Ltd is primarily involved in Medicinal Chemicals & Botanical Products, with SIC code 2833.

Does this filing indicate any new financial results or operational updates?

No, this Form 6-K appears to be a routine disclosure and does not contain specific financial figures or operational updates.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 23, 2025 regarding Bon Natural Life Ltd (BON).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing